Gizem Yayli-Vokshi
@gizemyv.bsky.social
Postdoctoral Associate @Weill Cornell Medicine
Previously @UniversiteEge🇹🇷 & @IGBMC 🇫🇷 & @JohnsHopkinsSPH 🇺🇸
Previously @UniversiteEge🇹🇷 & @IGBMC 🇫🇷 & @JohnsHopkinsSPH 🇺🇸
Reposted by Gizem Yayli-Vokshi
Extremely honoured to be the 2025 recipient of the Francois Wallace Monahan fellowship supporting my next 2 years of research on lung cancer metastasis in the Massagué group at MSK.
February 8, 2025 at 2:09 AM
Extremely honoured to be the 2025 recipient of the Francois Wallace Monahan fellowship supporting my next 2 years of research on lung cancer metastasis in the Massagué group at MSK.
Thrilled to share our recently published paper! It was a pleasure collaborating with such talented scientists on this work. Huge congrats to Kristin V Chesnutt, Michael G Poirier and @tlaszlo.bsky.social Proud to be part of it.
academic.oup.com/nar/advance-...
academic.oup.com/nar/advance-...
academic.oup.com
December 5, 2024 at 3:42 PM
Thrilled to share our recently published paper! It was a pleasure collaborating with such talented scientists on this work. Huge congrats to Kristin V Chesnutt, Michael G Poirier and @tlaszlo.bsky.social Proud to be part of it.
academic.oup.com/nar/advance-...
academic.oup.com/nar/advance-...
Happy to share our perspective article about HER2low subtype and endocrine therapy resistance is online! www.frontiersin.org/journals/onc...
Frontiers | The intersection of the HER2-low subtype with endocrine resistance: the role of interconnected signaling pathways
www.frontiersin.org
November 22, 2024 at 2:12 PM
Happy to share our perspective article about HER2low subtype and endocrine therapy resistance is online! www.frontiersin.org/journals/onc...